These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 12952231)

  • 1. Differential chemokine, chemokine receptor and cytokine expression in Epstein-Barr virus-associated lymphoproliferative diseases.
    Ohshima K; Karube K; Hamasaki M; Tutiya T; Yamaguchi T; Suefuji H; Suzuki K; Suzumiya J; Ohga S; Kikuchi M
    Leuk Lymphoma; 2003 Aug; 44(8):1367-78. PubMed ID: 12952231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imbalances of chemokines, chemokine receptors and cytokines in Hodgkin lymphoma: classical Hodgkin lymphoma vs. Hodgkin-like ATLL.
    Ohshima K; Karube K; Hamasaki M; Suefuji H; Tutiya T; Yamaguchi T; Suzumiya J; Kikuchi M
    Int J Cancer; 2003 Sep; 106(5):706-12. PubMed ID: 12866030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dominant expression of interleukin-10 and transforming growth factor-beta genes in activated T-cells of chronic active Epstein-Barr virus infection.
    Ohga S; Nomura A; Takada H; Tanaka T; Furuno K; Takahata Y; Kinukawa N; Fukushima N; Imai S; Hara T
    J Med Virol; 2004 Nov; 74(3):449-58. PubMed ID: 15368517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential chemokine, chemokine receptor, cytokine and cytokine receptor expression in pulmonary adenocarcinoma: diffuse down-regulation is associated with immune evasion and brain metastasis.
    Ohshima K; Hamasaki M; Makimoto Y; Yoneda S; Fujii A; Takamatsu Y; Nakashima M; Watanabe T; Kawahara K; Kikuchi M; Shirakusa T
    Int J Oncol; 2003 Oct; 23(4):965-73. PubMed ID: 12963975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-18, interferon-gamma, IP-10, and Mig expression in Epstein-Barr virus-induced infectious mononucleosis and posttransplant lymphoproliferative disease.
    Setsuda J; Teruya-Feldstein J; Harris NL; Ferry JA; Sorbara L; Gupta G; Jaffe ES; Tosato G
    Am J Pathol; 1999 Jul; 155(1):257-65. PubMed ID: 10393857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of chemokines, chemokine receptors, cytokines and cytokine receptors in diffuse large B cell malignant lymphoma.
    Fujii A; Ohshima K; Hamasaki M; Makimoto Y; Haraoka S; Utsunomiya H; Okazaki M; Kikuchi M
    Int J Oncol; 2004 Mar; 24(3):529-38. PubMed ID: 14767537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural Killer cell transcriptome during primary EBV infection and EBV associated Hodgkin Lymphoma in children-A preliminary observation.
    M A; Chatterjee S; A P; S M; Davuluri S; Ar AK; T A; M P; Cs P; Sinha M; Chugani A; R VP; Kk A; R S J
    Immunobiology; 2020 May; 225(3):151907. PubMed ID: 32044149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of Mig, the monokine induced by interferon-gamma, and IP-10, the interferon-gamma-inducible protein-10, in tissue necrosis and vascular damage associated with Epstein-Barr virus-positive lymphoproliferative disease.
    Teruya-Feldstein J; Jaffe ES; Burd PR; Kanegane H; Kingma DW; Wilson WH; Longo DL; Tosato G
    Blood; 1997 Nov; 90(10):4099-105. PubMed ID: 9354680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus-positive cytotoxic T-cell lymphoma followed by chronic active Epstein-Barr virus infection-associated T/NK-cell lymphoproliferative disorder: a case report.
    Kato S; Miyata T; Takata K; Shimada S; Ito Y; Tomita A; Elsayed AA; Takahashi E; Asano N; Kinoshita T; Kimura H; Nakamura S
    Hum Pathol; 2013 Dec; 44(12):2849-52. PubMed ID: 24012167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Favorable prognosis of renal cell carcinoma with increased expression of chemokines associated with a Th1-type immune response.
    Kondo T; Nakazawa H; Ito F; Hashimoto Y; Osaka Y; Futatsuyama K; Toma H; Tanabe K
    Cancer Sci; 2006 Aug; 97(8):780-6. PubMed ID: 16863511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults.
    Suzuki K; Ohshima K; Karube K; Suzumiya J; Ohga S; Ishihara S; Tamura K; Kikuchi M
    Int J Oncol; 2004 May; 24(5):1165-74. PubMed ID: 15067338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectrum of Epstein-Barr virus-associated T-cell lymphoproliferative disorder in adolescents and young adults in Taiwan.
    Wang RC; Chang ST; Hsieh YC; Huang WT; Hsu JD; Tseng CE; Wang MC; Hwang WS; Wang J; Chuang SS
    Int J Clin Exp Pathol; 2014; 7(5):2430-7. PubMed ID: 24966953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of chemokines in Hodgkin's disease.
    Teruya-Feldstein J; Tosato G; Jaffe ES
    Leuk Lymphoma; 2000 Jul; 38(3-4):363-71. PubMed ID: 10830743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus (EBV) load and cytokine gene expression in activated T cells of chronic active EBV infection.
    Ohga S; Nomura A; Takada H; Ihara K; Kawakami K; Yanai F; Takahata Y; Tanaka T; Kasuga N; Hara T
    J Infect Dis; 2001 Jan; 183(1):1-7. PubMed ID: 11106535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States.
    Cohen JI; Jaffe ES; Dale JK; Pittaluga S; Heslop HE; Rooney CM; Gottschalk S; Bollard CM; Rao VK; Marques A; Burbelo PD; Turk SP; Fulton R; Wayne AS; Little RF; Cairo MS; El-Mallawany NK; Fowler D; Sportes C; Bishop MR; Wilson W; Straus SE
    Blood; 2011 Jun; 117(22):5835-49. PubMed ID: 21454450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological analysis of the age-related differences in patients with Epstein-Barr virus (EBV)-associated extranasal natural killer (NK)/T-cell lymphoma with reference to the relationship with aggressive NK cell leukaemia and chronic active EBV infection-associated lymphoproliferative disorders.
    Takahashi E; Ohshima K; Kimura H; Hara K; Suzuki R; Kawa K; Eimoto T; Nakamura S;
    Histopathology; 2011 Oct; 59(4):660-71. PubMed ID: 22014047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of chronic active Epstein-Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency?
    Kimura H
    Rev Med Virol; 2006; 16(4):251-61. PubMed ID: 16791843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human eosinophils produce the T cell-attracting chemokines MIG and IP-10 upon stimulation with IFN-gamma.
    Dajotoy T; Andersson P; Bjartell A; Löfdahl CG; Tapper H; Egesten A
    J Leukoc Biol; 2004 Sep; 76(3):685-91. PubMed ID: 15197236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The understanding of Epstein-Barr virus associated lymphoproliferative disorder].
    Zhou XG; Zhang YL; Xie JL; Huang YH; Zheng YY; Li WS; Chen H; Liu F; Pan HX; Wei P; Wang Z; Hu YC; Yang KY; Xiao HL; Wu MJ; Yin WH; Mei KY; Chen G; Yan XC; Meng G; Xu G; Li J; Tian SF; Zhu J; Song YQ; Zhang WJ
    Zhonghua Bing Li Xue Za Zhi; 2016 Dec; 45(12):817-821. PubMed ID: 28056294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The chemokine and chemokine receptor profile of infiltrating cells in the wall of arteries with cardiac allograft vasculopathy is indicative of a memory T-helper 1 response.
    van Loosdregt J; van Oosterhout MF; Bruggink AH; van Wichen DF; van Kuik J; de Koning E; Baan CC; de Jonge N; Gmelig-Meyling FH; de Weger RA
    Circulation; 2006 Oct; 114(15):1599-607. PubMed ID: 17015796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.